The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: Gabapentin and pregabalin may be of therapeutic benefit

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 131-136

  Gazulla, José ^a   Tintoré, María ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CACNA1A PROTEIN; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; GABAPENTIN; PREGABALIN; PROTEIN; PROTEIN DERIVATIVE; SPINOCEREBELLAR ATAXIA 6 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA; CARBOXY TERMINAL SEQUENCE; CEREBELLUM ATROPHY; CHROMOSOME 19P; ELECTROPHYSIOLOGY; EXON; HUMAN; NEUROPATHOLOGY; NONHUMAN; OLIVOPONTOCEREBELLAR ATROPHY; OOCYTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT; XENOPUS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 33750629176     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.06.014     Document Type: Article

References (55)

1. 2+ channels. Annu Rev Cell Biol 16 (2000) 521-555
2. Llinás R., Sugimori M., Lin J.-W., and Cherksey B. Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison. Proc Natl Acad Sci USA 86 (1989) 1689-1693
3. 2+ channels in the mammalian central nervous system. Trends Neurosci 15 (1992) 351-355
4. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., and Adams M.E. P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature 355 (1992) 827-829
5. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA 6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet 15 (1997) 62-69
6. 2+ channel currents in rat cerebellar granule neurons. J Neurosci 15 (1995) 2995-3012
7. Stea A., Tomlinson J., Soong T.W., et al. Localization and functional properties of a rat brain α1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc Natl Acad Sci USA 91 (1994) 10576-10580
8. Volsen S.G., Day N.C., McCormack A.L., et al. The expression of neuronal voltage-dependent calcium channels in human cerebellum. Mol Brain Res 34 (1995) 271-282
9. Bajjalieh S.M., and Scheller R.H. The biochemistry of neurotransmitter secretion. J Biol Chem 270 (1995) 1971-1974
10. Mochida S., Westenbroek R.E., Yokoyama C.T., et al. Requirement for the synaptic protein interaction site for reconstitution of synaptic transmission by P/Q-type calcium channels. Proc Natl Acad Sci USA 100 (2003) 2819-2824
11. 2+ channels. Proc Natl Acad Sci USA 100 (2003) 3491-3496
12. Takahashi T., and Momiyama A. Different types of calcium channel mediate central synaptic transmission. Nature 366 (1993) 156-158
13. De Waard M., and Campbell K.P. Subunit regulation of the neuronal α1A calcium channel expressed in Xenopus oocytes. J Physiol 485 (1995) 619-634
14. 2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature 399 (1999) 155-159
15. 2+/calmodulin-dependent facilitation and inactivation of P/Q-type calcium channels. J Neurosci 20 (2000) 6830-6838
16. Charvin N., Lévêque C., Walker D., et al. Direct interaction of the calcium sensor protein synaptotagmine I with a cytoplasmic domain of the α1A subunit of the P/Q-type calcium channel. EMBO J 16 (1997) 4591-4596
17. Südhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 375 (1995) 645-653
18. 12.1 subunit. FEBS Lett 532 (2002) 300-308
19. Volsen S.G., Day N.C., McCormack A.L., et al. The expression of voltage-dependent calcium channel β subunits in human cerebellum. Neuroscience 80 (1997) 161-174
20. 2+ channels is a single transmembrane extracellular protein which is involved in regulated secretion. FEBS Lett 379 (1996) 15-20
21. Gao B., Sekido Y., Maximov A., et al. Functional properties of a new voltage-dependent calcium channel α2δ auxiliary subunit gene (CACNA2D2). J Biol Chem 275 (2000) 12237-12242
22. Marais E., Klugbauer N., and Hofmann F. Calcium channel α2δ subunits-structure and gabapentin binding. Mol Pharmacol 59 (2001) 1243-1248
23. Klugbauer N., Lacinová L., Marais E., Hobom M., and Hofmann F. Molecular diversity of the calcium channel α2δ subunit. J Neurosci 19 (1999) 684-691
24. Hobom M., Dai S., Marais E., Lacinová L., Hofmann F., and Klugbauer N. Neuronal distribution and functional characterization of the calcium channel α2δ-2 subunit. Eur J Neurosci 12 (2000) 1217-1226
25. 2+ channels. J Biol Chem 35 (2001) 32917-32924
26. Klugbauer N., Dai S., Specht V., et al. A family of γ-like calcium channel subunits. FEBS Lett 470 (2000) 189-197
27. Frontali M., and Jodice C. Spinocerebellar ataxia type 6. In: Manto M.U., and Pandolfo M. (Eds). The cerebellum and its disorders (2002), Cambridge University Press, Cambridge 451-458
28. Gómez C.M., Thompson R.M., Gammack J.T., et al. Spinocerebellar ataxia type 6: gaze-evoked nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 42 (1997) 933-950
29. Ishikawa K., Fujigasaki H., Saegusa H., et al. Abundant expression and cytoplasmic aggregations of α1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum Mol Genet 8 (1999) 1185-1193
30. Sinke R.J., Ippel E.F., Diepstraten C.M., et al. Clinical and molecular correlations in spinocerebellar ataxia type 6. A study of 24 dutch families. Arch Neurol 58 (2001) 1839-1844
31. Craig K., Keers S.M., Archibald K., Curtis A., and Chinnery P.F. Molecular epidemiology of spinocerebellar ataxia type 6. Ann Neurol 55 (2004) 752-755
32. Matsuyama Z., Kawakami H., Maruyama H., et al. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA 6). Hum Mol Genet 6 (1997) 1283-1287
33. van de Warrenburg B.P.C., Sinke R.J., Verschuuren-Bemelmans C.C., et al. Spinocerebellar ataxias in the Netherlands. Prevalence and age of onset variance analysis. Neurology 58 (2002) 702-708
34. Brusco A., Gellera C., Cagnoli C., et al. Molecular genetics of hereditary spinocerebellar ataxia. Mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 61 (2004) 727-733
35. Pujana M.A., Corral J., Gratacós M., et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. Hum Genet 104 (1999) 516-522
36. Sasaki H., Kojima H., Yabe I., et al. Neuropathological and molecular studies of spinocerebellar ataxia type 6 (SCA 6). Acta Neuropathol 95 (1998) 199-204
37. Tsuchiya K., Oda T., Yoshida M., et al. Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: report of two autopsy cases and statistical analysis of autopsy cases reported to date. Neuropathology 25 (2005) 125-135
38. Ishikawa K., Owada K., Ishida K., et al. Cytoplasmic and nuclear polyglutamine aggregates in SCA 6 Purkinje cells. Neurology 56 (2001) 1753-1756
39. Gomez C.M. Polyglutamine aggregates in SCA 6 Purkinje cells. A tail of two toxicities. Neurology 56 (2001) 1618-1619
40. 2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J Neurosci 19 (1999) RC141-RC145
41. Zoghbi H.Y. CAG repeats in SCA 6. Anticipating new clues. Neurology 49 (1997) 1196-1199
42. Toru S., Murakoshi T., Ishikawa K., et al. Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function. J Biol Chem 275 (2000) 10893-10898
43. Restituito S., Thompson R.M., Eliet J., et al. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a β subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J Neurosci 20 (2000) 6394-6403
44. 2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. J Neurosci 21 (2001) 9185-9193
45. Jen J.C., Yue Q., Karrim J., Nelson S.F., and Baloh R.W. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 65 (1998) 565-568
46. Yabe I., Sasaki H., Yamashita I., Takei A., and Tashiro K. Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry. Acta Neurol Scand 104 (2001) 44-47
47. Belliotti T.R., Capiris T., Ekhato I.V., et al. Structure-activity relationships of pregabalin and analogues that target the α2-δ protein. J Med Chem 48 (2005) 2294-2307
48. Kuzniecky R., Ho S., Pan J., et al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 58 (2002) 368-372
49. 2+ channels by gabapentin. FEBS Lett 528 (2002) 177-182
50. Gong H.C., Hang J., Kobler L., Li L., and Su T.Z. Tissue-specific expression and gabapentin-binding properties of calcium channel α2δ subunit subtypes. J Membr Biol 184 (2001) 35-43
51. Gazulla J., Errea J.M., Benavente I., and Tordesillas C.J. Treatment of ataxia in cortical cerebellar atrophy with the GAB Aergic drug gabapentin. Eur Neurol 52 (2004) 7-11
52. Gazulla J., and Benavente I. Mejori{dotless}́a sintomática de la atrofia olivopontocerebelosa con gabapentina. Rev Neurol 40 (2005) 285-288
53. Gazulla J, Benavente I, Sarasa M. Ataxia-telangiectasia del adulto. Observación cli{dotless}́nica y terapéutica. Neurologi{dotless}́a, 2006;21:in press.
54. v2.1 in absence epilepsy and episodic ataxia. Brain 127 (2004) 2682-2692
55. Trouillas P., Takayanagi T., Currier R.D., Subramony S.H., Wessel K., Bryer A., et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci 145 (1997) 205-211